WALTHAM, Mass., Nov. 14, 2014 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), a specialty pharmaceutical company, announced today that William Heiden, AMAG’s president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference in London on Thursday, November 20, 2014 at 9:20 a.m. GMT. The session will include a company presentation followed by a question and answer session, in which the company’s business and financial outlook, strategy and growth prospects will be discussed, including the acquisition of the maternal health business of Lumara Health Inc.
A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for 90 days.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, the treatment of iron deficiency anemia in patients with chronic kidney disease and cancer supportive care. The primary goal of AMAG and its maternal health division, Lumara HealthTM, is to bring to market therapies that provide clear benefits and improve patients’ lives. In addition to continuing to pursue opportunities to make new advancements in patients’ health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies, including revenue-generating commercial products and late-stage development assets that leverage the company’s corporate infrastructure, sales force call points and commercial expertise. For additional company information, please visit www.amagpharma.com.
AMAG PHARMACEUTICALS® is a registered trademark of AMAG Pharmaceuticals, Inc. LUMARA HEALTH™ is a trademark of Lumara Health Inc.
CONTACT: AMAG Pharmaceuticals, Inc.
Katie Payne, 617-498-3303
AMAG Pharmaceuticals, Inc.